A long-awaited study shows that screening for breast cancer with annual mammograms may not always be the best way to catch ...

In December 2022, Johnson enrolled in an early-stage clinical trial at the Cleveland Clinic that is testing a novel vaccine ...

Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...

The risk-based screening strategy was associated with similar detection rates for any cancer compared with annual screening ...

Cancer survivorship goes past treatment to focus on rebuilding strength, protecting function, and preventing complications ...

Pfizer’s Tukysa added to maintenance therapy significantly delayed disease progression in patients with HER2-positive ...

Use of preoperative MRI is variable across practices, but "there's really no clinical benefit," she said. "We have for a very ...

Male breast cancer is rare, but studies suggest it's more common — and more lethal — among veterans. Yet the Veterans Administration is making it harder for veterans with breast cancer to get care.

The phase 3 MajesTEC-3 trial demonstrated that the combination of the bispecific BCMA-directed T-cell engager teclistamab and ...

Lumpectomy has been the standard of care for low-risk, early-stage breast cancer, but now cryoablation — freezing cancer ...

Overall, tucatinib add-on to first-line maintenance therapy for HER2-positive metastatic breast cancer delayed progression by ...

The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...